Royal Bank of Canada’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6K | Sell |
|
|||||
|
2023
Q4 | $47K | Buy |
|
|||||
|
2023
Q3 | $16K | Buy |
|
|||||
|
2023
Q2 | $15K | Buy |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Sell |
|
|||||
|
2022
Q3 | $13K | Buy |
|
|||||
|
2022
Q2 | $21K | Hold |
|
|||||
|
2022
Q1 | $22K | Sell |
|
|||||
|
2021
Q4 | $14K | Buy |
|
|||||
|
2021
Q3 | $10K | Hold |
|
|||||
|
2021
Q2 | $13K | Hold |
|
|||||
|
2021
Q1 | $13K | Buy |
|
|||||
|
2020
Q4 | $0 | Sell |
|
|||||
|
2020
Q3 | $1K | Sell |
|
|||||
|
2020
Q2 | $1K | Sell |
|
|||||
|
2020
Q1 | $0 | Buy |
|
|||||
|
2019
Q4 | $0 | Buy |
|
|||||
|
2019
Q3 | $1K | Sell |
|
|||||
|
2019
Q2 | $1K | Hold |
|
|||||
|
2019
Q1 | $1K | Hold |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $378K | Sell |
|
|||||
|
2018
Q2 | $357K | Buy |
|
|||||
|
2018
Q1 | $583K | Buy |
|
|||||
|
2017
Q4 | $725K | Sell |
|
|||||
|
2017
Q3 | $1.05M | Buy |
|
|||||
|
2017
Q2 | $877K | Sell |
|
|||||
|
2017
Q1 | $2.18M | Sell |
|
|||||
|
2016
Q4 | $2.93M | Buy |
|
|||||
|
2016
Q3 | $4.54M | Sell |
|
|||||
|
2016
Q2 | $3.92M | Sell |
|
|||||
|
2016
Q1 | $6.11M | Buy |
|
|||||
|
2015
Q4 | $5.17M | Buy |
|
|||||
|
2015
Q3 | $459K | Sell |
|
|||||
|
2015
Q2 | $767K | Buy |
|
|||||
|
2015
Q1 | $702K | Sell |
|
|||||
|
2014
Q4 | $1.72M | Buy |
|
|||||
|
2014
Q3 | $983K | Buy |
|
|||||
|
2014
Q2 | $740K | Sell |
|
|||||
|
2014
Q1 | $520K | Buy |
|
|||||
|
2013
Q4 | $11K | Sell |
|
|||||
|
2013
Q3 | $17K | Buy |
|
|||||
|
2013
Q2 | $13K | Buy |
|